Gastric cancer is the second leading cause of cancer death worldwide (Roder, 2002). The prognosis is generally poor, with an overall 5-year survival of approximately 20% in most countries. The median ...

UFT is an oral anticancer agent composed of tegafur and uracil at a 1 : 4 fixed molar ratio (Fujii et al, 1979). Although the clinical effectiveness of the single agent against advanced non-small-cell ...

Neoadjuvant therapy for adenocarcinomas of the duodenum and ampulla of Vater. Background: This phase II study evaluated efficacy of fixed dose rate (FDR) infusion of gemcitabine (10mg/m 2 /min) and ...

Phase II study of induction chemotherapy (ICT) with gemcitabine (G) and vinorelbine (V) followed by concurrent chemoradiation therapy (CCRT) with oral etoposide (E) and cisplatin (P) for inoperable ...